SGH
DXCM icon

Sivik Global Healthcare’s DexCom DXCM Stock Holding History

Sivik Global Healthcare’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,000
Closed -$3.4M – 39
2024
Q2 		$3.4M Sell
30,000
-5,000
-14% -$632K 1.52% 30
2024
Q1 		$4.86M Sell
35,000
-15,000
-30% -$1.89M 1.77% 31
2023
Q4 		$6.21M Hold
50,000
– – 2.59% 17
2023
Q3 		$4.67M Buy
+50,000
New +$5.64M 2.36% 25
2019
Q2 		– Sell
-50,000
Closed -$1.49M – 63
2019
Q1 		$1.49M Buy
50,000
+20,000
+67% +$703K 0.55% 56
2018
Q4 		$899K Sell
30,000
-50,000
-63% -$1.59M 0.48% 43
2018
Q3 		$2.86M Buy
80,000
+36,400
+83% +$1.13M 1.03% 42
2018
Q2 		$1.03M Buy
+43,600
New +$924K 0.4% 59

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return